Clinical Trial Update: A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer [Phase 3]

View source ↗

Summary

This clinical trial update indicates completion of a Phase 3 study evaluating androgen annihilation in high-risk biochemically relapsed prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Alliance Foundation Trials, LLC. | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED